FIA
ACET icon

FNY Investment Advisers’s Adicet Bio ACET Stock Holding History

FNY Investment Advisers’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,200
Closed -$21K – 845
2026
Q1 		$21K Sell
3,200
-2,900
-48% -$21.7K 0.01% 462
2025
Q4 		$51K Buy
+6,100
New +$67.4K 0.01% 442

FNY Investment Advisers's ACET Position: Q2 2026 in Review

FNY Investment Advisers sold out of Adicet Bio (ACET) in Q2 2026, closing a stake of 3,200 shares — an estimated $21K sold.

FNY Investment Advisers first reported a position in ACET in Q4 2025 and held it in 2 quarters. The position peaked at $51K in Q4 2025. 0 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • FNY Investment Advisers reported no remaining Adicet Bio position as of Q2 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 3,200 Adicet Bio shares in Q2 2026, an estimated $21K.
  • FNY Investment Advisers first reported a position in Adicet Bio in Q4 2025 and held it in 2 quarters.
  • FNY Investment Advisers's Adicet Bio position peaked at $51K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.